
COVID’s Impact on Innovations in Regulatory Affairs
While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...
1 year agoCOVID’s Impact on Innovations in Regulatory Affairs
While the impact of COVID-19 was significant in every area of the pharmaceutical sector, some of the most pandemic’s most overlooked impacts were within the regulatory space. From study design to submissions, the virus affected every aspect of drug regulation,...
1 year ago
Challenges and Opportunities in Pharmaceutical Manufacturing
The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....
1 year agoChallenges and Opportunities in Pharmaceutical Manufacturing
The rapid change in demand for pharmaceutical products during the COVID-19 pandemic sent shockwaves throughout the industry. Since the start of the crisis, pharma manufacturers have implemented a number of innovations to streamline the production process from start to finish....
1 year ago
Latest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease
Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...
1 year agoLatest Advancements in Parkinson’s Treatment: CGT Shows Potential to Reverse Disease
Every hour, two more people are diagnosed with Parkinson’s in the UK and the global patient population continues to rise. To date, there are no disease-modifying therapies available on the market for Parkinson's (PD) patients. Pharmaceutical company Bayer is simultaneously...
1 year ago
Strategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi
In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....
1 year agoStrategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi
In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....
1 year ago
Evaluating Advancements in Drug Discovery
Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...
1 year agoEvaluating Advancements in Drug Discovery
Innovations in medicinal chemistry have seen significant developments in drug discovery techniques. From drug screening to pharmacokinetics, the industry has worked hard to optimise target identification and validation for important therapeutic developments. The latest advancements have demonstrated the value of...
1 year ago
Aseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
1 year agoAseptic Processing: Maintaining Sterility in Pharmaceutical Manufacturing
In 2019, drug manufacturer Genzyme was thought to have lost up to $300m in revenue due to plant shutdown after product contamination. Ensuring appropriate aseptic practices are followed can mean the difference between efficient manufacturing operations and the shutting down...
1 year ago
Emerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
1 year agoEmerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
1 year ago
How Has COVID Affected Pharmaceutical Manufacturing?
In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...
1 year agoHow Has COVID Affected Pharmaceutical Manufacturing?
In 2020 the COVID-19 pandemic threw the world into turmoil. The pharmaceutical industry needed to adapt rapidly to meet an increased demand, shifting clinical trials to virtual platforms and of course looking to accelerate COVID vaccine approval. It has become...
1 year ago
A Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
1 year agoA Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
1 year ago
Future Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
1 year agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
1 year ago